BioWorld

April 6, 2005

View Archived Issues

Avigen Dropping AAV Gene Therapy, Favoring Tradition

In what has proved to be a slow and somewhat bumpy road for gene therapy research, one company - Avigen Inc. - is gracefully bowing out in order to focus on more traditional drug development. (BioWorld Today) Read More

Absalus, EvoGenix Merging To Combine Antibody Efforts

Read More

Lorus Bringing Antisense Drug To Collaboration With Sumitomo

Read More

BioWorld's Biotechnology State Of The Industry Report 2005 Available

Read More

Other News To Note

Read More

Appointments And Advancements

Read More